Drugs in the treatment of gastric and duodenal ulcer.
D000687:Amylopectin / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004967:Estrogens / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D006035:Glycyrrhiza; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010946:Plants, Medicinal; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy*; D015032:Zinc / Q000627:therapeutic use
D000863:Antacids; D004967:Estrogens; D005231:Fatty Acids, Unsaturated; D006635:Histamine H2 Antagonists; D007093:Imidazoles; D010276:Parasympatholytics; D011465:Prostaglandins, Synthetic; D002792:Cholestyramine Resin; D000687:Amylopectin; D015032:Zinc; D008787:Metoclopramide; D002229:Carbenoxolone; D001729:Bismuth